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Abstract.  Clathrin heavy chain-deficient mutants 
(chcl)  of Saccharomyces  cerevisiae  are viable but ex- 
hibit compromised growth rates.  To investigate the role 
of clathrin in intercompartmental protein transport, 
two pathways have been monitored in chcl cells: trans- 
port of newly synthesized vacuolar proteins to the 
vacuole and receptor-mediated uptake of mating phero- 
mone.  Newly synthesized precursors of the vacuolar 
protease carboxypeptidase Y  (CPY)  were converted to 
mature CPY with similar kinetics in mutant and wild- 
type cells, chcl cells did not aberrantly secrete CPY 
and immunolocalization techniques revealed most of 
the CPY in chcl cells within morphologically identifi- 
able vacuolar structures.  Receptor-mediated internali- 
zation of the mating pheromone a-factor occurred in 
chcl cells at 36-50%  wild-type levels. The mutant 
cells were fully competent to respond to 
pheromone-induced cell-cycle arrest.  These results ar- 
gue that in yeast, clathrin may not play an essential 
role either in vacuolar protein sorting and delivery or 
in receptor-mediated endocytosis of a-factor. Alterna- 
tive mechanisms ordinarily may execute these pathways, 
or be activated in clathrin-deficient cells. 
least two avenues of intracellular protein traffic ser- 
vice lysosomes in mammalian cells and lysosome- 
like vacuoles in yeast. Newly synthesized lysosomal 
and vacuolar enzymes follow the secretory pathway from the 
endoplasmic  reticulum to  the  Golgi  body  (11, 39).  After 
traversing Golgi body cisternae, the enzymes are diverted 
from the secretory pathway at an undefined location and de- 
livered to their final residence. One branch of the endocytic 
pathway also  leads  to  lysosomes (or  vacuoles).  In  mam- 
malian  cells,  both  fluid-phase and  receptor-mediated  en- 
docytosis involve transfer of extracellular molecules to an en- 
dosomal  compartment  (19). Endosomal  sorting  reactions 
direct traffic between several  pathways,  one of which leads 
to lysosomes. Although not as extensively characterized in 
yeast, both fluid-phase and receptor-mediated internaliza- 
tion have been described (7, 22,  36). 
Transfer of molecules between compartments along both 
lysosome-oriented routes is thought to be mediated by trans- 
port vesicles (11, 19). Clathrin-coated membranes and vesi- 
cles have been implicated as key intermediates in the forma- 
tion of these transport vesicles (15, 35). The most compelling 
example of an association between clathrin and transport 
vesicle generation has been provided by studies of receptor- 
mediated endocytosis in mammalian cells (15, 16). Initially, 
receptor-bound ligands are concentrated along indented do- 
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mains (pits) of the plasma membrane that are decorated on 
the cytoplasmic surface with a polygonal protein lattice. The 
predominant component of the lattice is clathrin. Clathrin- 
coated pits invaginate and bud, forming clathrin-coated vesi- 
cles laden with receptors and associated ligands.  Vesicles 
quickly shed their coat before fusion with the subsequent 
endocytic  compartment.  Less  extensive  biochemical  and 
morphological evidence has been garnered in support of a 
similar role for clathrin during vesicle generation in other in- 
tercompartmental transport pathways, including the route fol- 
lowed by newly synthesized lysosomal enzymes (3, 4, 12, 34). 
In  vitro,  clathrin  exhibits  properties  that  are  uniquely 
suited for participation in membrane vesiculation. The poly- 
hedral  lattice  on purified clathrin-coated vesicles  can  be 
depolymerized to yield "triskelions" composed of three clath- 
rin heavy chains (each 180 kD) and three clathrin light chains 
(usually two species varying in size from 30-40  kD)  (26, 
47).  Triskelions can assemble to form empty lattice cages 
(26) or rebind to vesicles previously stripped of their clathrin 
coats (46). 
From these studies, a model emerged which suggested that 
polymerization of clathrin triskelions into polyhedral cages 
drives formation of coated vesicles from coated membrane 
regions (17, 35).  In addition, specific interactions between 
the clathrin coats, or an associated protein, and membrane 
proteins and receptors carrying ligands could insure collec- 
tion of cargo proteins at membrane sites engaged in vesicle 
formation (16, 31, 35).  In this view, clathrin plays a pivotal 
role in the biogenesis and selectivity of transport vesicles. 
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Yeast strain  Genotype  Source or reference 
GPY1100  MATa 1eu2-3,-112 ura3-52 his4-519 trpl can1  Strain TD4 from G.  R.  Fink* 
GPY 1101  chcl-A 8::LEU2 transformant of GPY 1 I00  32 
GPY1103  chcl-A8:LEU2  transformant of GPY1100  32 
GPY74-29B  MA Ta 1eu2-3,-112 ura3-52 pep4  : : URA3 his4-519 trp  l  prb  l  sst  l  This study 
GPY79.1  chcl-A IO::LEU2 transformant of GPY74-29B  This study 
GPY79.2  chcl-AIO::LEU2  transformant of GPY74-29B  This study 
GPY68  MATa  chcl-AIO::LEU2 leu2-3,-112 ura3-52 his4-519 trpl prbl  This study 
GPY56-26C  MATa 1eu2-3,-112,  ura3-52, ade2 his6,  trpl,  met1,  sstl prbl  This study 
GPY70.3  chcl-AIO::LEU2  transformant of GPY56-26C  This study 
* Department of Biology, Massachusetts Institute of Technology, Cambridge, MA. 
In  earlier  reports  we  have described the  generation of 
clathrin  heavy chain-deficient mutants  of Saccharomyces 
cerevisiae (32, 33). Yeast strains harboring null alleles of the 
single clathrin heavy chain gene (CHC1) are viable but ex- 
hibit reduced growth rates. Viable cells devoid of clathrin- 
coated vesicles provide a means to determine whether clath- 
rin is required for various intracellular transport reactions. 
Such a direct test of biological function has not been avail- 
able  previously.  Here  we  investigate the  integrity of two 
transport pathways in clathrin-deficient  ceils: transfer of newly 
synthesized vacuolar proteins to the vacuole and receptor- 
mediated internalization of peptide mating pheromone. 
Materials and Methods 
Strains, Media, and Genetic Methods 
Yeast strains used in this study are listed in Table I.  YPD is YP medium 
(1% Bacto-Yeast  extract, 2 % Bactopeptone; Difco Laboratories, Inc., De- 
troit,  MI) with 2%  glucose. Solid YPD medium contained 2%  agar. For 
[ass]so42--labeling, cells were  grown in Wickerham's minimal medium 
(51) except sulfate salts were replaced by chloride salts and ammonium sul- 
fate was added to the desired concentration. The absorbance of dilute cell 
suspensions was measured in a  1-cm cuvette at 600 nm in a Zeiss PMQII 
spectrophotometer. Standard genetic methods were used for CHC1 strain 
constructions (42). chcl::LEU2  and pep4::URA3 strains were generated by 
single step gene transplacement as described elsewhere (33). Plasmid pTSI5 
used to disrupt PEP4 is reported in Rothman et al.  (38). 
Radiolabeling,  Preparation of  Lysates, 
and Immunoprecipitations 
Cells were grown overnight to midlogarithmic phase at 30°C in minimal 
medium plus 2%  glucose and 200 I.tM ammonium sulfate. For labeling, 
cells  were  harvested by  centrifugation,  washed,  and  resuspended at  2 
OD600 per ml in minimal medium plus 2%  glucose without ammonium 
sulfate. Labeling was initiated by adding 200 IxCi of [35S]SO42-- (1,200 Ci/ 
mmol; ICN Blochemicals, Inc., Irvine, CA) per OD600. After labeling at 
30°C, ammonium  sulfate (3 mM), cysteine (0.01%),  and methionine (0.01%) 
were added. To detect internal carboxypeptidase Y (CPY) ~, samples were 
collected  at designated time intervals, placed on  ice,  and sodium azide 
added to 10 mM. Upon completion of the time course, cells were lysed by 
agitation with glass beads and SDS as described (33). To measure both in- 
ternal and secreted CPY, after labeling, cells were mixed with an equal vol- 
ume of minimal medium with 2% glucose, 500 I.tg/ml ovalbumin or BSA 
and ammonium sulfate, cysteine, and methionine at concentrations cited 
above. Ovalbumin and BSA stabilize secreted CPY (45). At each time point, 
cells were collected by centrifugation, the medium removed, 10 mM sodium 
1. Abbreviations  used in this paper: CPY, carboxypeptidase Y; YPD, YP 
medium (1%  Bacto-Yeast  extract,  2%  Bactopeptone);  TAME, p-tosyl-L- 
arginine methyl ester. 
azide added to the cell pellet, and both fractions placed on ice. Cell lysates 
were prepared as described above. Medium fractions received SDS to a final 
concentration of 0.8%.  All samples were heated at 100°C for 3 min, then 
adjusted to final concentrations of 20 mM sodium phosphate pH 7.2,  135 
mM sodium chloride,  1% Triton X-100, and 0.4%  SDS. Immunoprecipita- 
tion techniques and SDS-PAGE analysis are described in Stevens et al. (45). 
Densitometry has been previously reported (33). Each form of CPY in Fig. 
2 is expressed as the percentage of the total density value of all three forms 
at the time point. The total values varied up to 20% between time points. 
a-Factor Uptake and Binding Assays 
35S-labeled  a-factor was prepared and purified as described by Chvatchko 
et al. (7). The specific activity of the purified peptide was '~1 Ci/mmol as 
determined by halo assay. Thin layer chromatography revealed two spots in 
accordance with results reported by Chvatchko et al.  (7). 
For uptake determinations we applied a modification of the assay used 
by Chvatchko et al. (7). Cells were grown overnight in YPD to an ODt,00 
of ",,1, then washed, and resuspended at 30 OD600/ml in pH 5.5 YP plus 
5.0% glucose, 5 mM p-tosyl-L-arginine methyl ester (TAME), and 0.2 mM 
phenylmethylsulfonyl fluoride (PMSF).  35S-labeled  a-factor was added to 
a final concentration of 10  -s M and the cultures incubated with shaking at 
24°C. At time intervals, 100 I.tl samples were removed and diluted into 2 ml 
of ice-cold 50 mM sodium citrate, pH 2. After 20 rain on ice, cells were 
collected  on glass fiber  filters  (GFC  Whatman, Inc.,  Clifton,  NJ)  and 
washed with 20 ml of the citrate buffer. Filters were dried and counted in a 
liquid scintillation counter for l0 min with Beta-Max scintillant (West Chem, 
San Diego, CA). 200 OD~0/ml of strain GPY74-29B internalized 63 % of 
l0  -8 M a-factor in 75 min at 24°C. This value was taken as the percentage of 
ass-labeled peptide that was biologically active.  In several experiments, 
replacement assays were conducted on 20-min time point samples to deter- 
mine the amount of biologically active a-factor remaining in the medium. 
Cells were removed by centrifugation and GPY74-29B cells added to 200 
OD600/ml and incubated at 24°C for 75 min. In each case (CHC1 MATa, 
chcl MATa, and chcl MATa strains), the sum of the counts internalized by 
cells in the first 20-min incubation and GPY74-29B cells in the replacement 
incubation corresponded to the amount of biologically active 35S-labeled 
a-factor added at the onset. 
For a-factor cell surface binding measurements,  cells grown as described 
above were resuspended at various concentrations in pH 5.5 YP medium 
plus 10 mM potassium fluoride,  10 mM sodium azide, 5 mM TAME, and 
0.2 mM PMSF (inhibitor medium). 35S-labeled  a-factor was added to 10  -s 
M and the samples incubated with shaking at 24°C. After 25 min, samples 
were diluted into 2-ml inhibitor medium, collected onto glass fiber filters, 
and washed three times with 2 ml inhibitor medium. Filters were dried and 
counted as above. 
Halo Assays 
a-Factor was purified from the medium of MATa cells through the Bio-Rex 
70 (Bio-Rad Laboratories, Richmond, CA) column step described in Ciejek 
and Thorner (8). 
For halo assays, cells were grown overnight in YPD to an OD600 of 1-2. 
0.10D600 U of cells were suspended in YPD plus 0.75%  molten agar and 
then plated onto solid YPD.  a-Factor was diluted into 20% methanol, 0.4 
mM 2-mercaptoethanol, and applied to the cell lawn as 5-I.tl drops. Halos 
were scored after 40 h at 30°C for CHCI  cells and 60 h at 30°C for chcl 
cells. 
The Journal of Cell Biology, Volume 106,  1988  1454 Figure  1.  CPY  processing  in  clathrin-deficient  and  wild-type 
strains.  CHC1 strain GPYI100 and chcl-A8 strain GPYll03 were 
pulse-labeled for 5 min with [35S]SO42-, then allowed to continue 
growth in the presence of excess unlabeled SO42- methionine and 
cysteine to prevent further labeling. Samples were harvested at the 
designated times after initiation of the chase, cells lysed, and CPY 
immunoprecipitated. Precipitated CPY was resolved and visualized 
by SDS-PAGE and autoradiography, pl,  p2,  and CPY  (mature) 
forms are described in the text. 
Electron Microscopy 
The procedures for fixation, embedding in Lowicryl resins, and immuno- 
labeling are detailed in van Tuinen and Riezman (49). 
Results 
A  general  strategy has been adopted to assess  the role of 
clathrin in various intercompartmental traffic routes. Sets of 
congenic  clathrin-deficient  (chcl)  and  wild-type  (CHC1) 
strains were generated by using single-step gene transplace- 
ment to disrupt CHC1 in haploid cells (33). chcl Transfor- 
mants obtained by this technique were isogenic with the pa- 
rental  CHC1 haploid,  except at  the  CHC1 locus.  Mutant 
strains grew two to three times more slowly than their wild- 
type counterparts. Pairs of congenic strains were then sub- 
jected to phenotypic analyses. 
ProCPY  Is Matured at Wild-type Rates in chcl Cells 
The vacuolar protease CPY  provides a  diagnostic  tool to 
characterize transit of newly synthesized proteins to the vac- 
uole. CPY is translated as an inactive zymogen that acquires 
four core oligosaccharides upon translocation into the en- 
doplasmic reticulum (18, 44). By SDS-PAGE, this form (pl 
CPY) has a mobility corresponding to 67 kD. During transit 
through the Golgi apparatus, a discrete addition of mannose 
residues produces the 69-kD p2  species  (44).  Proteolytic 
maturation of p2 CPY to enzymatically active CPY (m form, 
61  kD) most likely takes place in the vacuole (9,  44,  53). 
Conversion of pl to p2 to mCPY can easily be monitored by 
SDS-PAGE. 
The time course of proCPY modification was examined in 
congenic sets of CHC1 and chcl strains using a pulse-chase 
regimen. Cells were labeled for 5  min with [35S]SO42- and 
then allowed to continue growth in the presence of excess un- 
labeled SO4  -2,  cysteine, and methionine.  Total  cell lysates 
were prepared  from cells  collected at  intervals  after im- 
plementation of the  chase.  CPY  was  immunoprecipitated 
from each lysate and resolved on SDS-polyacrylamide gels. 
As shown in Fig.  1, top,  proCPY synthesized in wild-type 
cells undergoes the anticipated, ordered series of mobility 
shifts. In mutant cells (Fig.  1, bottom), mCPY appears at a 
wild-type rate, although the conversion of pl to p2 CPY is 
somewhat abnormal. Densitometric analyses of the autora- 
diograms in Fig.  1 substantiates these conclusions (Fig. 2). 
In both mutant and wild-type cells, 50% of the proCPY has 
been matured at ~9 min of chase (Fig. 2 A). Compared with 
CHC1 cells, a slight delay in the processing ofpl CPY is evi- 
dent in mutant cells:  t,~ is  3.2  min in  CHC1 cells and 5.8 
min in chcl cells (Fig. 2 B). Also, the p2 form in mutant cells 
accumulates to only 50% of the wild-type level at the 5-min 
chase points. The same results were obtained with two other 
sets of congenic strains. These experiments argue that, as as- 
sayed by proCPY maturation, a lack of clathrin heavy chain 
does not alter the rate of CPY delivery to the vacuole. There 
appears to be, however, a slight but reproducible anomaly in 
the ability of mutant cells to convert pl  to p2 CPY. 
proCPY Is Not Secreted by chcl Strains 
Mislocalization of proCPY has been observed in three in- 
stances: overexpression of CPY from a multicopy plasmid 
carrying the CPY structural gene PRC1 (45); mutation of the 
vacuolar address determinant on CPY (24, 48); mutation of 
other genes involved in directing traffic to the vacuole (2, 
37). In each case, at least 40% of the proCPY escaped sort- 
ing, was packaged into secretory vesicles, and secreted as p2 
CPY into the medium. By comparison, wild-type strains se- 
crete 1-5 % of newly made proCPY. 
To examine the possibility that chcl cells fail'to segregate 
proCPY from the secretory pathway,  CPY secreted into the 
medium of mutant and wild-type stains was quantified. After 
a 15-min labeling period, congenic strains were incubated for 
45 min in chase medium. Samples were harvested at 0 and 
45 min of chase and CPY was immunoprecipitated from cell 
lysates (Fig. 3  C) and medium fractions (Fig. 3 M).  SDS- 
PAGE analysis of  precipitated CPY, shown in Fig. 3, revealed 
that wild-type and mutant strains export similarly low levels 
of CPY. When corrected for the amount loaded on the gel 
(see legend to Fig.  3), <5 % of the total CPY was detected 
the medium of each strain.  Analyses conducted with three 
other pairs of congenic partners gave simlar results.  Also, 
chcl  cells  did  not  secrete another vacuolar protein,  pro- 
teinase A (not shown). In each experiment, parallel cultures 
of wild-type strains bearing PRC1 on a  multicopy plasmid 
exported •50%  of the  total  CPY  as  the p2  form.  Thus, 
clathrin-deficient cells retain the ability to sort vacuolar pro- 
teases from the secretory pathway with high fidelity. 
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Figure 2. Kinetics of CPY modification 
in chcl CHC1 cells. Different autoradio- 
graphic exposures of the gels presented 
in Fig.  1 were quantified by densitome- 
try. (A) Rate of mature CPY appearance. 
(Solid circles) CPY  from CHC! strain 
GPYII00.  (Open triangles) CPY  from 
chcl-A8  strain  GPYll01.  (B)  Rate  of 
precursor CPY modification. (Solid cir- 
cles)  CPY  precursors  from  GPYII00. 
(Open triangles) CPY precursors  from 
GPYll01.  Solid symbols  represent  pl 
CPY. Open symbols represent p2 CPY. 
CPY in chcl Cells Is Present in Vacuoles 
Immunolocalization of CPY  in  thin  sections  from mutant 
cells was undertaken to identify the subcellular residence of 
CPY. Fig. 4, A-C show electron micrographs of thin sections 
of achc! strain stained with afffinity-purified  anti-CPY anti- 
bodies and protein A-gold complexes. For comparison, Fig. 
4  D  depicts  a  similarly processed congenic  CHC1 strain. 
Vacuoles were located by their dense, granular contents en- 
closed within a  membrane bilayer. This distinctive charac- 
teristic,  revealed by uranylacetate and lead acetate (or lead 
citrate)  staining,  is a  commonly used criterion  for vacuole 
identification  (37, 40,  49).  Clathrin-deficient  mutant  cells 
routinely  exhibit  accumulated  membrane  organelles  and 
vacuolar  structures  (arrowheads)  that  appear  more  frag- 
mented and are more frequently multivesicular in cross sec- 
tion  than  vacuoles in  wild-type cells  (33).  In spite of the 
different  internal  morphologies  of  mutant  and  wild-type 
cells,  most of the  CPY  in  both  cell  types  resides  within 
vacuolar structures. In both mutant and wild-type cells, a low 
degree  of  labeling  was  present  over  organelles  (arrows) 
smaller than the major vacuolar compartments. At present, 
the precise identification of these smaller structures is uncer- 
tain.  They could  represent  smaller  autonomous  vacuoles, 
convolutions of the vacuole that appear as distinct structures 
in  cross  section,  or  another  distinct  membrane  compart- 
ment.  Small numbers  of protein A-gold complexes in  the 
cytoplasm represent background  also  observed in  cells  in 
which PRC1 has been deleted  (not shown). 
It is clear, in summary, that clathrin-deficient cells can sort 
newly synthesized CPY from the secretory pathway and de- 
liver it to vacuoles. 
was  accompanied  by  a  concomitant  loss  of  cell-surface 
receptor activity, presumably due to receptor-ligand inter- 
nalization  (22). 
A  modified version of the assay described by Chvatchko 
et al. (7) was used to measure uptake of radiolabeled a-factor 
Endocytosis by chcl Cells 
As described in the Introduction,  studies of receptor-medi- 
ated endocytosis have provided the single demonstration of 
clathrin's  association  with  membrane vesiculation.  Recent 
reports  have  presented  evidence  for  internalization  of the 
peptide pheromone a-factor by MATa yeast, a-Factor uptake 
bears the  hallmarks of receptor-mediated endocytosis:  up- 
take  depends  on  time,  temperature,  energy,  and  specific 
cell-surface receptors (7, 22).  Furthermore, peptide uptake 
Figure 3.  chcl cells do not secrete CPY  into the medium.  CHC1 
strain GPYll00  and chcl-A8 strain GPYII03 were labeled for  15 
min with [3sS]SO42-, then subjected to a chase regimen as described 
in Materials and Methods. Samples were collected at 0 and 45 min 
of chase and separated into cell (C) and medium (M) fractions. Cell 
lysates were prepared and CPY immunoprecipitated and displayed 
as in Fig.  1. M lanes (even-numbered lanes) received four times as 
much immunoprecipitated material to enhance detection of secreted 
CPY. 
The Journal of Cell Biology. Volume  106,  1988  1456 Figure 4.  Immunolocalization of CPY.  Strains  GPYII03 (A-C) and  GPYII00 (D)  were  processed for CPY  immunolocalization  (see 
Materials and Methods).  Thin sections of cells were incubated with affinity-purified anti-CPY antibodies.  Bound antibodies  were decorated 
with protein  A-gold complexes.  Large arrowheads point to vacuolar structures  labeled  with protein A-gold. Note the multiple  vacuolar 
structures  in A-C that often appear multivesicular.  In contrast, the CHC1 strain in D exhibited a single large vacuole. Small arrows indicate 
undefined  membrane organelles  containing label,  n, the nucleus.  Bars,  0.5 p,m. 
by wild-type and clathrin-deficient cells.  Purified 35S-labeled 
a-factor was added to chcl sstl MATa or CHC1 sstl MATa 
cells (10  -s M  a-factor, 3  ×  10  s cells/ml).  The sstl mutation 
eliminates  a  secreted protease  which degrades  a-factor (6, 
8). After incubation at 24°C, cells were collected and washed 
with  pH2  buffer,  pH2  treatment  strips  a-factor  bound  to 
receptors at the cell surface leaving only internalized peptide 
associated with cells (7; Baker, D., unpublished results).  In 
our first experiments,  despite the sstl  mutation,  exogenous 
a-factor was rapidly inactivated by chd, but not CHC1, cells. 
Viable staining with methylene blue indicated that '~5 % of 
the mutant cells were inviable whereas <0.1%  of the wild- 
type cells were dead. It seemed possible that ~t-factor inacti- 
vation  resulted  from degradation  by proteases  released  by 
inviable  chcl  cells.  To  circumvent  this  problem,  genetic 
and biochemical strategies were applied. First, prbl (52) and 
pep4  (20)  mutant  alleles  were  introduced  into  chcl  and 
CHC1 strains to lower the level of endogenous vacuolar pro- 
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Figure 5.  Uptake and binding of a-factor by MATa chcl and MATa CHC1 strains. (A) chcl cells internalize a-factor. MATa CHC1 strain 
GPY74-29B (solid squares) and MATa chcl strain GPY79.1 (open squares) were suspended at 3  ×  108 celis/ml in YP plus 5% glucose, 
5 mM TAME, and 0.2 mM PMSE a-Factor was added to 10  -g M and cells incubated at 24°C. At the designated times, cells were har- 
vested and assayed for internalized a-factor by washing with pH2 buffer as described  in Materials and Methods.  (B) a-Factor uptake is 
energy and receptor dependent,  a-Factor was measured after 20 min at 24°C as described in A. Samples without energy contained 10 mM 
sodium azide and 10 mM sodium fluoride in place of glucose. The bars indicate average values obtained from multiple experiments using 
MATa CHC1 strain GPY74-29B, chcl-AlO derivatives 79.1 and 79.2, and chcl-AlO MATa strain GPY68. In each experiment the amount 
of a-factor internalized by the MATa CHC1 strain was taken as 100%. (C) a-Factor binding. GPY74-29B (CHC1) and GPY79.1 (chcl-AlO) 
were incubated with 10  -8 M a-factor in YP medium plus 10 mM potassium fluoride,  10 mM sodium azide, 5 mM TAME, and 0.2 mM 
PMSF for 25 min at 24°C. Bound a-factor was measured by washing with the incubation medium as described in Materials and Methods. 
teolytic activity. Second, protease inhibitors TAME (8) and 
PMSF  were added to the incubations.  Under these condi- 
tions, both chcl and CHC1 strains internalized a-factor (Fig. 
5  A).  The clathrin-deficient  cells accumulated  a-factor at 
nearly half the rate of wild-type cells.  Fig. 5 B illustrates a 
compilation of results from several experiments. In four ex- 
periments,  after 20  min  at  24°C,  uptake by  chcl  strains 
ranged from 36 to 50 % of wild-type levels (with "no energy" 
background  subtracted).  Internalization  was  temperature 
(not shown) and energy dependent (compare first two bars 
with third and fourth bars in Fig.  5 B).  Finally, uptake of 
a-factor by chcl cells was receptor mediated since MATa chcl 
cells, which do not express a-factor receptor, failed to take 
up pheromone (Figure 5 B, fifth bar). 
Reduced uptake of a-factor by chcl strains did not result 
from degradation  of exogenous pheromones or decreased 
binding capacities.  Degradation was examined using a cell 
replacement assay. An incubation of chcl cells (either MATa 
or MATa) with labeled a-factor at 24°C was terminated after 
20 min by sedimenting the cells.  The supernatant  fraction 
was then incubated with fresh CHC1 cells for 75 min at 24°C. 
The amount of radiolabel internalized during the two incuba- 
tions  equalled  the  amount  of biologically  active  ct-factor 
added initially (see Materials and Methods). Thus, during a 
20-rain incubation with mutant cells, no significant degrada- 
tion of a-factor was observed. This experiment also indicated 
that the absence of a-factor internalization  by chcl MATa 
cells was  not due  to competition from unlabeled  a-factor 
secreted by cells during the incubation. Binding of a-factor 
was measured at 24°C by incubating labeled pheromone with 
varying concentrations of cells in the presence of energy in- 
hibitors to prevent internalization (23; also see Materials and 
Methods).  Bound  or-factor was determined after a  pH 5.5 
wash. Fig. 5 C demonstrates that binding to chcl and CHC1 
ceils was identical. 
In the assay described by Chvatchko et al. (7) internalized 
or-factor  was  rapidly degraded.  We  were unable  to detect 
degradation of internal pheromone in either mutant or wild- 
type cells. This probably reflects the lowered proteolytic ac- 
tivity due to the prbl and pep4 mutations. Y. Chvatchko and 
H.  Riezman have made  a  similar  observation using pep4 
strains (personal communication). 
We have also attempted to measure fluid-phase uptake of 
Lucifer Yellow CH (36).  Unfortunately, the level of dye ac- 
cumulated in our wild-type strains was barely detectable. In 
addition, a high background accumulation of dye by inviable 
chcl cells precluded unequivocal determination of dye up- 
take. 
MATa chcl Cells Respond Normally to a-Factor 
Mutant  yeast strains defective in  accumulation of a  fluid- 
phase endocytic marker, Lucifer Yellow  CH, are unable to 
respond physiologically to or-factor (7). One of these strains, 
harboring the  endl  mutation,  fails  to  internalize  a-factor. 
These studies correlate endocytic capacity with the ability to 
respond to mating pheromone. 
The experiment illustrated in Fig. 6 indicates that the re- 
duced rate of a-factor uptake by chcl cells had no effect on 
one response to a-factor, cell-cycle arrest. The sensitivities 
of chcl  and  CHC1  cells  to  cell-cycle arrest  imposed  by 
a-factor were compared by spotting dilutions of pheromone 
onto lawns of cells. Zones of arrested cells appear as clear- 
ings or "halos" in the lawn. The radius of the halo is a mea- 
sure of the sensitivity of cells in the lawn to pheromone (25). 
Equal  halo  sizes  were  produced  by  two-fold  dilutions  of 
a-factor spotted onto lawns of chcl and CHC1 cells (Fig. 6). 
Our results argue that receptor-mediated endocytosis can 
occur in the absence of clathrin heavy chain,  albeit at re- 
duced  rates,  chcl  null  alleles do not alter the cellular re- 
sponses of MATa cells to or-factor  and,  accordingly, MATa 
chcl cells mate at near wild-type efficiencies (not shown). 
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a-factor. MATa CHC sstl strain 
GPY56-26C and MATa chcl- 
AIO sstl strain GPY70.3 were 
plated as a lawn of 106 cells 
on  YPD  medium.  Two-fold 
dilutions of 2 ×  10  -6 M a-fac- 
tor  were  spotted starting  at 
the 2 o'clock position. The 12 
o'clock position received only 
solvent in which the a-factor 
was diluted. Plates were incu- 
bated at 30°C for 40 (GPY56- 
26C) or 60 h (GPY70.3). Areas 
of clearing termed "halos" rep- 
resent zones of growth-arrested 
cells. 
Discussion 
Aspects of two intracellular transport pathways have been ex- 
amined in clathrin heavy chain-deficient yeast. Mutant cells 
properly localize newly synthesized vacuolar proteases and 
carry out receptor-mediated  uptake of a-factor mating phero- 
mone. Clathrin is therefore, unexpectedly, not required for 
either pathway, or can be replaced by a functional homologue 
in clathrin-deficient cells. 
Transport of  Newly Synthesized Proteins to the Vacuole 
Comparison of CPY transport in chcl and CHC1 strains has 
shown that mCPY appears at identical rates. Precursor CPY 
molecules are efficiently  diverted from the secretory pathway 
and  immunolocalization studies  located most CPY  mole- 
cules  in  vacuolar  structures.  These  findings  argue  that 
clathrin does not provide a necessary function during vacuo- 
lar protein sorting and delivery. However, a slight defect was 
apparent in the conversion of pl to p2 CPY in mutant cells. 
The reduced rate of glycosyl maturation of pl  CPY in chcl 
cells could represent an effect of clathrin deficiency on man- 
nosyltransferase activity or organization, but ifpl CPY were 
transported from the Golgi apparatus to the vacuole, lower 
molecular mass forms of mCPY would be expected, mCPY 
from  CHC1  and  chcl  migrate  identically  on  SDS-PAGE 
(Payne, G. S., unpublished data). While the anomalous delay 
in glycosyl maturation of CPY in chcl strains remains unex- 
plained, there appears to be no compromise in the rate of for- 
mation of the proteolytically mature enzyme. 
These results contrast sharply with the characteristics of 
yeast mutant strains selected for mislocalization of vacuolar 
proteins (vpl mutants [37]; vpt mutants [2]). Mutations in as 
many as 50 genes have been obtained by selecting for effi- 
cient secretion of carboxypeptidase Y in a precursor or hy- 
brid protein form.  Many of these mutant strains  secrete a 
large fraction of CPY in a proenzyme form and the kinetics 
of transport are comparable to that observed for a  typical 
secreted protein. In spite of a dramatic reduction in the intra- 
cellular levels of soluble vacuolar proteins, many of these 
mislocalization  mutants  exhibit  normal  rates  of growth. 
Clearly, the clathrin heavy chain gene is not a member of the 
vacuole protein sorting gene family. 
Protease A is required for maturation of proCPY (1), yet 
when it is mislocalized along with proCPY in vpl or vpt mu- 
tants,  both molecules persist in a  precursor form (2,  37). 
Once again, in contrast to this phenotype, chcl mutant cells 
produce and retain mature protease A  (unpublished data). 
It is unlikely that mature CPY and protease A are formed 
before the vacuolar protein sorting event in chcl mutant cells. 
The essential sorting determinant has been identified in the 
propeptide segment of both proteases (24, 27, 48). Deletion 
of this signal(s) results in secretion of the mutant protease. 
Hence, premature processing of proCPY would remove the 
localization signal and result in mature,  secreted CPY. 
Although our results imply that clathrin is dispensible in 
transport of vacuolar proteins, they do not exclude the possi- 
bility  that  newly  made  proteins  pass  through  a  clathrin- 
coated compartment  in  route to  the  vacuole.  This  seems 
likely in the lysosome-oriented pathway in mammalian cells. 
Lysosomal hydrolases an6 the cation-independent, 212-kD 
mannose-6-phosphate receptor (involved in selective target- 
ing of lysosomal protein to lysosomes) have been identified 
in purified clathrin-coated vesicles (4, 5, 41). In addition, im- 
munocytochemical studies have revealed lysosomal proteins 
and mannose-6-phosphate receptors in coated regions of the 
Golgi apparatus and in coated vesicles (3,  13,  14). Similar 
studies of yeast vacuolar proteins await more purified prepa- 
rations of clathrin-coated vesicles and elucidation of the in- 
tracellular distribution of clathrin-coated membranes. 
Endocytosis 
We have measured internalization of a-factor to assess recep- 
tor-mediated endocytosis by chcl cells. Jenness and Spatrick 
(22) and  Chvatchko et al.  (7) have recently provided evi- 
dence for uptake of a-factor via an endocytic pathway.  Inter- 
nalization of a-factor is temperature, energy, and receptor 
dependent and is accompanied by a loss of surface binding 
sites. Mutant yeast strains defective in fluid-phase accumula- 
tion of Lucifer Yellow CH are also unable to take up a-factor. 
Uptake of a-factor into the vacuole has been confirmed by 
direct visualization of 3H-labeled pheromone as autoradio- 
graphic grain tracks on thin sections (Chvatchko, Y, E. van 
Tuinen,  and  H.  Riezman,  unpublished  results).  Further- 
more, internalized a-factor is not degraded in strains lacking 
active  vacuolar  proteases  (pep4).  Proof of an  endocytic 
mechanism awaits  the detection of a vesicular intermediate 
in the uptake of these molecules. 
a-Factor is internalized by yeast cells in which clathrin has 
been specifically and completely eliminated. Although this 
result was unexpected, portents have been reported in studies 
of mammalian cells. Huet et al. (21) stimulated endocytosis 
of human fibroblast histocompatibility antigens with an anti- 
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microscopy has shown that uptake occurs through surface in- 
vaginations and endocytic vesicles that do not display clath- 
rin  coats.  Another group  (29)  reported that  inhibition of 
clathrin-coated pit formation in human Hep2 cells by intra- 
cellular K ÷ depletion completely blocks  transferrin  inter- 
nalization but  reduces endocytosis of ricin toxin by only 
50 %. Both of these studies suggest the existence of a clath- 
rin-independent endocytic pathway.  In  a  more direct ap- 
proach, two groups have microinjected anticlathrin antibod- 
ies  into  living  cells  and  measured  the  endocytosis  of 
molecules known to enter cells through clathrin-coated inter- 
mediates.  In  one  case,  uptake  of  ct2-macroglobulin,  no 
effect was observed (50). In the second study, a 50% diminu- 
tion of Semliki forest virus endocytosis was obtained (10). 
Based on the studies using mammalian cells, and the data 
presented here, it appears that clathrin is not essential for 
receptor-mediated endocytosis. Thus, clathrin cannot be the 
sole mediator of plasma membrane vesiculation during en- 
docytosis. Our studies do not distinguish between three pos- 
sible interpretations of this conclusion: (a) clathrin does not 
directly provide the  force necessary to generate a  vesicle 
from the plasma membrane but, instead, expedites endocyto- 
sis through other capacities such as clustering certain surface 
receptors; (b) clathrin normally is the factor responsible for 
vesicle formation during receptor-mediated endocytosis but 
another protein can provide complementing function;  (c) 
both clathrin-dependent and -independent pathways exist and 
~t-factor is normally internalized by a clathrin-independent 
route. 
The reduced uptake of a-factor by chcl cells is difficult to 
interpret and could reflect any of the scenarios just listed. If 
clathrin serves an auxiliary role in all endocytosis or if a 
heavy chain functional homologue exists, then elimination of 
CHC1 could expose less efficient endocytic pathways.  On the 
other  hand,  ct-factor  may  normally enter cells  through  a 
clathrin-independent route and the reduced internalization in 
chcl cells may be an indirect consequence of defects in other 
transport pathways.  Isolation of conditonally defective CHC1 
alleles and attempts to identify clathrin heavy chain homo- 
logues should aid in distinguishing these possibilities. 
Recently, the sequence of the putative structural gene for 
the ~t-factor receptor, STE2, has been determined (30). The 
deduced amino acid sequence reveals a protein with seven 
potential membrane-spanning domains. This structural mo- 
tif is shared by mammalian cell I~-adrenergic  receptors (see 
reference 43  for review).  In contrast,  other growth factor 
and  nutrient  receptor  polypeptides,  such  as  epidermal 
growth  factor and  low  density  lipoprotein receptors,  are 
predicted to span the membrane only once. With this distinc- 
tion in mind, it may be relevant that, unlike epidermal growth 
factor and low density lipoprotein receptors, ~adrenergic 
receptors are internalized (termed sequestration) by an un- 
defined mechanism (43). In particular, it is unclear whether 
internalization occurs through clathrin-coated intermediates. 
Lemmon and Jones (28)  have identified a  unique yeast 
strain that is inviable when CHC1 is disrupted. Inviability is 
due to a single genetic locus, named SCD1, which is unlinked 
to CHC1. In contrast, we have surveyed >10 strains from four 
separate laboratories without observing a locus that leads to 
inviability when combined with  chcl  (33).  It thus  seems 
likely that the strain described by Lemmon and Jones har- 
bors an infrequent, possibly altered allele of SCD1. This al- 
lele could mark a gene whose product can normally substi- 
tute for clathrin directly, or indirectly as a component of a 
parallel pathway.  However, other less relevant explanations 
could apply and further information is needed to establish 
the nature of SCDI  (see reference 33 for a detailed discus- 
sion). The existence of SCD1 does not affect our conclusions 
that transport to the vacuole and endocytosis can be sustained 
in the absence of clathrin. 
Finally, we caution against concluding from our studies 
that clathrin does not play an important role in intracellular 
protein transport. Yeast cells devoid of clathrin heavy chain 
display compromised growth rates, accumulation of mem- 
brane organelles, a Golgi body or postGolgi body delay in 
export of  a secreted protein, and a reduced ability to internal- 
ize a-factor (32, 33). Preliminary results also indicate that 
another late Golgi or nascent secretory vesicle event, proteo- 
lytic maturation of the  a-factor precursor,  is disturbed  in 
MATa chcl cells.  Hence, although clathrin is not required 
for the essential functions originally postulated, it may facili- 
tate a  subset of intracellular transport processes.  Further- 
more, alternative mechanisms that back up clathrin function 
in normal cells may be pressed into service or even enhanced 
in clathrin-deficient cells. 
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